Trends of Patient-reported Outcome Measures (PROMs) in Multimorbid Medical Patients Hospitalized for an Acute Illness
TRADUCE
1 other identifier
observational
1,000
1 country
1
Brief Summary
currently, PROMs and PREMs are not routinely collected and compared among medical inpatients of Swiss university hospitals, nor is a standard set of PROMs and PREMs available for use in Swiss hospitals. The project aims to examine trends in patient-reported outcomes (PROMs), including symptoms, quality of life, and distress, in multimorbid hospitalized patients from admission to 30 days post-discharge. It will also investigate whether PROMs at discharge are linked to the risk of readmission or emergency visits and explore how these outcomes differ in patients who receive low-value care. Additionally, the project will assess the relationship between patient-reported experiences (PREMs) and the provision of low-value care during the hospital stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 21, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedSeptember 19, 2024
September 1, 2024
2.2 years
August 21, 2024
September 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation of PROMS with the risk of readmission
The primary objective of the project is to explore trends in PROMs (using the Edmonton Symptom Assessment System (ESAS-r), the EQ-5D-5L index,45 and the National Comprehensive Cancer Network (NCCN) distress thermometer) of multimorbid medical hospitalized patients, from admission until 30-days post-discharge. The patients-reported outcomes will consist of patients-reported symptoms, quality of life and distress
Day 1, Day 3, at the day of discharge (approximately day 8) and Day 30 after discharge from Hospital
Secondary Outcomes (3)
Correlation of PROMs at discharge and risk of hospital readmission or ED visits
Day 30 after discharge from hospital
Exploration of PROMs in patients who receive low-value care
Day 1, Day 3, at the day of discharge (approximately day 8) and Day 30 after discharge from Hospital
Explore PREMs
Since 24 hours after beginning of the hospitalization up to Discharge from Hospital (approximately day 8)
Study Arms (1)
multimorbid patients in general internal medicine divisions of all five Swiss university hospitals
Interventions
The investigators collect PROMs amongst up to 1000 patients in general internal medicine divisions of all five Swiss university hospitals
Eligibility Criteria
Patients with 2 or more chronic diseases, hospitalized in general internal medicine divisions of all five Swiss university hospitals
You may qualify if:
- eligible for the LUCID registry (CER-VD AO\_2023-00029) \[Age ≥ 18 years, hospitalized in one of the five participating university hospitals (Geneva, Lausanne, Bern, Zürich, Basel), after 01.01.2014, and admitted to general internal medicine wards
- Multimorbid patients (2 or more chronic diseases, defined as chronic conditions defined by international classification of diseases, 10th revision, codes with an estimated expected duration of at least 6 months or based on a clinical decision.
- Acute illness
- Signature of study specific informed consent
You may not qualify if:
- Not able to speak French, German or English
- Foreseen length of stay of less than 4 days (estimated by study collaborators)
- Incapacity of discernment, i.e. cognitive impairment which could interfere with the ability to fill in PROMs tools
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Lausanne Hospitalslead
- Insel Gruppe AG, University Hospital Berncollaborator
- University Hospital, Genevacollaborator
- University Hospital, Zürichcollaborator
- University Hospital, Basel, Switzerlandcollaborator
Study Sites (1)
Lausanne University Hospital
Lausanne, Canton of Vaud, 1005, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jerome Stirnemann, MD
University Hospital, Geneva
- PRINCIPAL INVESTIGATOR
Carole Aubert, MD
Bern University Hospital
- PRINCIPAL INVESTIGATOR
Florence Vallelian Cervetto, MD
Zürich University Hospital
- PRINCIPAL INVESTIGATOR
Stefano Bassetti, MD
Basel University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Senior Physician
Study Record Dates
First Submitted
August 21, 2024
First Posted
September 19, 2024
Study Start
July 1, 2023
Primary Completion
August 31, 2025
Study Completion
October 1, 2025
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share